Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Leslie Ochs"'
Autor:
Kirk E Evoy, Charles E Leonard, Jordan R Covvey, Leslie Ochs, Alyssa M Peckham, Samantha Soprano, Kelly R Reveles
Publikováno v:
Substance Abuse: Research and Treatment, Vol 14 (2020)
Background: As opioid-related overdose deaths climb in the U.S., risk reduction measures are increasingly important. One such measure recommended involves provision of proactive substance use counseling regarding the risks of opioid analgesics. This
Externí odkaz:
https://doaj.org/article/90c290d5812240e3b51fb9f43cc597fd
Publikováno v:
Substance Abuse: Research and Treatment, Vol 12 (2018)
Gabapentin is widely used in the United States for a number of off-label indications, often as an alternative to opioid therapy. Increasing evidence has emerged suggesting that gabapentin may not be as benign as once thought and may be associated wit
Externí odkaz:
https://doaj.org/article/b3558c3c55e74956aef94f55181d25c5
Autor:
Tamzin J. Batteson, Marianne G. Chirica, Kelli S. Fox, Jan Froehlich, Sarah S. Garber, Carol Lambdin-Pattavina, Sally A. McCormack Tutt, Leslie Ochs, Kira Rodriguez, Nancy Jo Ross, Lori Thuente
Publikováno v:
Journal of Interprofessional Education & Practice. 31:100617
Autor:
Jordan R. Covvey, Kelly R. Reveles, Alyssa M. Peckham, Samantha E. Soprano, Charles E. Leonard, Leslie Ochs, Kirk E. Evoy
Publikováno v:
Substance Abuse: Research and Treatment, Vol 14 (2020)
Substance Abuse: Research and Treatment
Substance Abuse: Research and Treatment
Background: As opioid-related overdose deaths climb in the U.S., risk reduction measures are increasingly important. One such measure recommended involves provision of proactive substance use counseling regarding the risks of opioid analgesics. This
Autor:
Kelly R. Reveles, Laura Roccograndi, Samantha Le, Alyssa M. Peckham, Jordan R. Covvey, Kirk E. Evoy, Leslie Ochs, Samantha E. Soprano, Charles E. Leonard
Publikováno v:
Journal of substance abuse treatment. 119
Research has recommended a combination of pharmacotherapy and behavioral therapy to treat opioid use disorder (OUD) or alcohol use disorder (AUD). The objective of this study was to estimate the prevalence of U.S. outpatient visits in which patients
Publikováno v:
Journal of Substance Use. 23:36-42
It is important to assess which dispensed medications remain unused as accumulated home medications serve as a source for poisonings, abuse, and misuse. The objective of this study was to characterize and quantify controlled substances relinquished a
Autor:
Oscar W. Garza, Monina R. Lahoz, Paul L. Ranelli, Abby A. Kahaleh, Suzanne Clark, Leslie Ochs, Radha V. Patel, Diana Isaacs, Natalie A. DiPietro Mager
Publikováno v:
Public Health Reports. 132:298-303
To collect data on public health collaborations with schools of pharmacy, we sent a short electronic survey to accredited and preaccredited pharmacy programs in 2015. We categorized public health collaborations as working or partnering with local and
Autor:
Leslie Ochs, Jennifer Danielson, Nina Pavuluri, Timothy M. Moore, Anand Krishnan V. Iyer, Rajender R. Aparasu, Samit Shah, Christopher Williams, Kathleen M.K. Boje, Kurt A. Wargo, Shareen Y. El-Ibiary, Jennifer D. Robinson
Publikováno v:
American journal of pharmaceutical education. 83(6)
Members from Cohort 13 of the Academic Leadership Fellows Program (ALFP) 2016-2017 were challenged to present a debate on the topic: "In Turbulent Times, Pharmacy Education Leaders Must Take Aggressive Action to Prevent Further Declines in Enrollment
Autor:
Jordan R. Covvey, Kathleen A. Fairman, Alyssa M. Peckham, Leslie Ochs, David A. Sclar, Kirk E. Evoy
Publikováno v:
Pharmacotherapy. 38(4)
Objective Research suggests medical consequences of gabapentin overuse depends on whether gabapentin is abused alone or with opioids to potentiate an opioid “high.” The objective of this study was to assess predictors of gabapentin overuse with o
Publikováno v:
Research in socialadministrative pharmacy : RSAP. 15(8)
Background Reports of gabapentinoid (gabapentin and pregabalin) misuse have increased in recent years. Pharmacovigilance data from the Food and Drug Administration Adverse Event Reporting System (FAERS) provides a useful examination of adverse drug e